Savant Capital, LLC

Position in MRNA — Moderna, Inc.

CIK 1482880 ROCKFORD, IL

Position in MRNA

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$520,462

+$242,825 QoQ

Shares Held

7,432

+217.9% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#372

of 772 holders

Holding Since

Dec 2021

11 quarters on record

Voting authority Sole 59% Shared 31% None 10%

Healthcare · as of Jun 30, 2026

Savant Capital, LLC holds $23,538,035 across 24 Biotechnology names. MRNA ranks #8 (2.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	26,241	$13,034,691
2	REGN	Regeneron Pharmaceuticals, Inc.	3,687	$2,298,991
3	JAZZ	Jazz Pharmaceuticals plc	4,776	$1,150,872
4	BBIO	BridgeBio Pharma, Inc.	12,479	$929,435
5	RPRX	Royalty Pharma plc	16,059	$900,428
6	CORT	Corcept Therapeutics Inc	6,935	$602,998
7	IONS	Ionis Pharmaceuticals Inc	7,476	$592,772
8	MRNA	Moderna, Inc. This page	7,432	$520,462

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$520,462	7,432	+217.9%	Shares	Sole	2026-08-10
2024-06-30	$277,637	2,338	-28.4%	Shares	Sole	2024-08-05
2024-03-31	$348,131	3,267	+7.3%	Shares	Sole	2024-05-06
2023-12-31	$302,725	3,044	-8.7%	Shares	Sole	2024-02-05
2023-09-30	$344,368	3,334	-18.2%	Shares	Sole	2023-11-07
2023-06-30	$494,991	4,074	+71.8%	Shares	Sole	2023-08-04
2023-03-31	$364,138	2,371	+12.2%	Shares	Sole	2023-05-03
2022-12-31	$379,537	2,113	+22.6%	Shares	Sole	2023-02-13
2022-09-30	$203,744	1,723	+31.9%	Shares	Sole	2022-10-31
2022-03-31	$224,971	1,306	+11.2%	Shares	Sole	2022-05-05
2021-12-31	$298,172	1,174	—	Shares	Sole	2022-02-08
No filing history on record for this holder in this stock.